Inventor · disambiguated record
Marie-Laure Nevoret
Also filed as: NEVORET MARIE-LAURE
1 granted patent·5 pending applications·1 citations·filing 2021–2023
17Inventor score
Top patents by PatentIndex Score
6 records- 0178US11986515B2Treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfatase (IDS)REGENXBIO INC·Filed 2023·Granted May 21, 2024·1 cites·30 claims
- 0254US2024117328A1Treatment of mucopolysaccharidosis ii with recombinant human iduronate-2-sulfatase (ids)REGENXBIO INC·Filed 2022·Application pending·0 cites
- 0353US2024316217A1Methods for preventing cardiac or skeletal defects in diseases including mucopolysaccharidosesUNIV MINNESOTA·Filed 2022·Application pending·0 cites
- 0444US2024091380A1Gene therapy for neuronal ceroid lipofuscinosesREGENXBIO INC·Filed 2022·Application pending·0 cites
- 0540US2023088992A1Treatment of mucopolysaccharidosis ii with recombinant human iduronate-2-sulfatase (ids) produced by human neural or glial cellsREGENXBIO INC·Filed 2021·Application pending·0 cites
- 0639US2023059395A1Treatment of mucopolysaccharidosis i with fully-human glycosylated human alpha-l-iduronidase (idua)REGENXBIO INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marie-Laure Nevoret files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →